Naturally Splendid (
TSXV:NSP,
Forum) has had a big week, announcing details about their
P OS Biosciences facility purchase and, today, that they had signed a
distribution deal with a Swiss company, Medropharm GmbH, that will add that company’s edible, CBD-rich hemp powder to its product offerings.
“Our cultivation and inventory are sufficient to allow Naturally Splendid to generate annual sales of our cannabidiol (CBD) products at approximately US $10m,” said Medropharm CEO Patrick Widmer.
Medropharm is no small deal. They currently, by their count, have six R&D projects underway, along with 15 products on the market and a crop area of 3.5 hectares.
Here is a video of an extreme close-up of a CBD crystal growing in a petri dish, with muzak, that Medropharm published a few months back. I’m not entirely sure what it’s in aid of, but hey.
https://www.youtube.com/watch?v=XRZ61x9aFzg&feature=player_embedded
And they tweet.
https://twitter.com/medropharm/status/602006600510001152/photo/1
NSP holders were being impatient nerds last week, selling off stock as the company worked out deals like this in corporate silence. I was one of them; I rolled the dice that we’d get through another few days without news, sold some NSP to pay for another stock purchase (which never panned out) and, sure enough, I missed the halt and a 13% jump.
Because I’m an idiot.
I’d expect NSP to linger a little around its present $0.455 level while some newly free-trading stock is cleared away, but I’ve re-purchased what I sold and will leave it be for a while; lesson learned.
NSP is doing all the right things to scale up quickly, and doing deals with companies that don’t play. With the
Laguna Blends sale, their
pet care line drawing big praise, the P OS Biosciences facility acquisition, the launch of their
bulk ingredient division, their
hiring of NFL (and Millionaire Matchmaker) veteran Mitch Berger, and now the Swiss deal, the pieces are in place.
Set it and forget it.
https://www.youtube.com/watch?v=T09cbIfrzoU&feature=player_embedded